Marijuana stock investors are working to stay poised during this ongoing volatile downtrend. Now even though the public sector is in a downtrend has not stopped industry progression as companies continue to generate large amounts of revenue. The cannabis industry has seen significant advancements in 2025. Much of which has been marked by increased and improved legalization. In addition to more companies working with technological innovations, and an expanding health and wellness market with cannabis as the focus.

More states and countries are recognizing the potential economic benefits of cannabis. With this, an increase in the growing number of regions have legalized both medicinal and recreational use. This expanded legal framework has attracted major investors which is why the frustrations are at an all-time high with the public sector. To enhance the trading performance of cannabis stocks, several scenarios could be beneficial. Firstly, greater transparency and standardization in product labeling can build consumer trust and confidence in cannabis products.

Additionally, enhancing regulatory clarity can attract institutional investors who have previously avoided the sector due to legal uncertainties. All of the above play a factor in trusting the market regardless of what is occurring. It is a classic risk vs reward with how things are in the sector. Nevertheless, there is still optimistic speculation for some shareholders and investors. Below are several marijuana stocks to watch and learn about over the Memorial Day break.

Marijuana Stocks To Know About In 2025

1. Leafly Holdings, Inc. (OTC:LFLY)
2. WM Technology, Inc. (NASDAQ:MAPS)
3. High Tide Inc. (NASDAQ:HITI)

Leafly Holdings, Inc.

Leafly Holdings, Inc. operates as an online cannabis discovery marketplace and resource in the United States and internationally. It has been a bit of time since the company has released any current updates.

However, on January 16th, the company held a receipt of notice of delisting from the Nasdaq and transition to OTC market.

WM Technology, Inc.

WM Technology, Inc., an online cannabis marketplace, provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. On May 8th the company reported its Q1 2025 results.

First Quarter 2025 Financial Highlights

• Revenues for the first quarter ended March 31, 2025 was $44.6 million as compared to $44.4 million in the prior year period.
• Average monthly paying clients(1) of 5,179 increased from 4,937 in the prior year period, largely due to new client acquisitions across certain markets.
• Net income increased to $2.5 million from $2.0 million in the prior year period.
• Adjusted EBITDA(3) increased to $10.1 million from $9.6 million in the prior year period.

[Read More] Top Marijuana Stocks In A Volatile Market

Words From The Company

“Our first quarter results reflect focused execution in what remains a challenging environment for the cannabis industry,” said Doug Francis, CEO of WM Technology. ”

[Read More] 2025’s Best Cannabis REITs for Building Wealth Over Time

High Tide Inc.

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. It operates through Bricks and Mortar Operations; and E-commerce Operations segments.

In recent news the company announced the opening of new Canna Cabana store in Cornwall, Ontario. This opening brings High Tide’s total store count to 197 Canna Cabana branded locations across Canada, and 81 in the province of Ontario.

The post 3 Marijuana Stocks That Could Be The Long Term Money Maker appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.

But this has yet to help how marijuana stocks perform. There has been a volatile downturn for some time, and even with the progress of business pot stocks won’t move up. Now, with this success for legal operators around the globe, it gives hope for those who want to enter the sector. For instance, watching how an MSO powerhouse like Trulieve can make all this money but trade poorly. Yet even with the market down, the success outside of the public sector keeps positive speculation going. Many feel this is the time to find top marijuana stocks to buy.

People feel the future is where the gains will be made. A classic buy-and-hold long-term strategy is what many are feeling will be the better option. When federal reform matters are met, it has the potential to bring the trading up in a major way. Many are keeping watch for any volatile pops o trading to take profits until the big payday occurs. Below are several marijuana stocks to watch today.

Marijuana Stocks For Investors Who Like Legal Cannabis 2025

1. Tilray Brands, Inc. (NASDAQ:TLRY)
2. Canopy Growth Corporation (NASDAQ:CGC)
3. Cronos Group Inc.(NASDAQ:CRON)

Tilray Brands, Inc.

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. 

The company recently announced that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours. This product is a new line of cannabis beverages and gummies that redefine the sour experience.

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

Recently, the company announced it will release its Q1 2025 financial results on May 30th. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Judy Hong, CFO.

[Read More] Marijuana Stocks To Buy Today And Trade Tomorrow?

Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. Back on May 8th, the company reported its Q1 2025 earnings.

[Read More] Top Performing U.S. Marijuana Stocks to Watch in 2025

2025 Highlights And Key Mentions

• Net revenue of $32.3 million in Q1 2025 increased by $7.0 million from Q1 2024.
• Gross profit of $13.7 million in Q1 2025 increased by $9.3 million from Q1 2024.
• Adjusted Gross Profit of $14.3 million in Q1 2025 increased by $9.8 million from Q1 2024.
• Net income of $7.7 million in Q1 2025 increased by $10.2 million from Q1 2024.

The post Top Marijuana Stocks In A Volatile Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry is still showing signs of profitability, with companies reporting strong 2025 earnings. Much of the legal market, even with its uphill battle, is standing strong. This shows people that even though it is not federally legal, there is still an abundance of success at the state level. As well as other legal markets in various global regions, all of which play a big role as a whole for cannabis.

Yet much of this success has not exactly translated into better trading for public cannabis companies. The bulk of marijuana stocks are still facing a massive downtrend. However, there is hope for the future and daily bounces that many investors want to take gains as they come. Now, due to how unpredictable the sector can be, there is no way to know when a monumental bounce will happen.

So the idea is that as things progress for legal cannabis down the line, that will help fuel better trading for cannabis stocks. Many feel that once federal reform comes into play, it will ease volatile trading. Most shareholders do not feel safe to make trades or invest as they would with it in place. Cannabis should be seen as a legitimate industry like any other, especially with the large tax revenue legal states are making. Hopefully, this will soon carry over to the public sector to help some of these top marijuana stocks to watch today.

Marijuana Stocks For Long-Term Investing

1. Trulieve Cannabis Corp. (OTC:TCNNF)
2. GrowGeneration Corp. (NASDAQ:GRWG)
3. Curaleaf Holdings, Inc. (OTC:CURLF)

Trulieve Cannabis Corp.

Trulieve Cannabis Corp. operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. 

In more recent news the company announced the opening of a new Trulieve-branded dispensary in Lorain, Ohio. Harvest Grows LLC will operate the dispensary under the Trulieve brand through a licensing agreement with the Company.

Words From The Company

“We are thrilled to open this new dispensary under our licensing agreement with Trulieve,” said Harvest’s Chief Executive Officer, Mark Eiland. “We are proud to be associated with the Trulieve brand and look forward to serving customers at this new location.”

[Read More] These 2 Marijuana Stocks Are Making Money Outside Of The Stock Market

GrowGeneration Corp.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. It operates through two segments, Cultivation and Gardening, and Storage Solutions. Recently, the company announced the launch of MMI Storage Solutions’ new mobile package and luggage solution.

It was designed exclusively for the Waldorf Astoria, one of the world’s most iconic luxury hotel brands. This custom-engineered system will elevate the Waldorf guest experience. The new setup will be done by providing hotel staff with an elegant, efficient, and secure way to handle guest luggage.

[Read More] 3 Marijuana Stocks For Cannabis Real Estate Investors

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. On May 16th the company released news regarding the opening of a new dispensary in Lima Ohio.

The store expands Curaleaf’s footprint in the Buckeye State to three stores, bringing the Company’s nationwide retail footprint to 152 locations. Curaleaf Lima will increase convenient access to high-quality cannabis for both medical patients and adult-use customers across northwest Ohio.

The post Marijuana Stocks To Buy Today And Trade Tomorrow? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Marijuana stock investors are at the mercy of not just the market but the politics of the entire industry. What this means is that with no federal reform and a lack of regulatory matters met the public sector for cannabis stocks is at all-time lows. Right now, if you are interested in cannabis, you can buy marijuana stocks to buy at lower-than-normal share prices.

Now, many are waiting patiently, and many have grown in frustration. For instance, how can businesses be booming for legal operators, and none of that success has led to better trading? At one point in time, when legal operators did well, so did the market. But that is not the case, and many have been taking profits as they can when they can catch a volatile pop in trading. Now for some time, any upward trading has been short-lived making it nearly impossible to see any gains.

Yet, with how well the cannabis industry as a whole is doing, future gains keep people optimistic. Right now is more of and buy-and-hold time, where shares are so low that this strategy could be profitable. It’s all about patience, strategizing, and choosing the right cannabis stocks to invest in. Below are a few marijuana stocks to watch that could be among the few to see momentum increase.

Marijuana Stocks To Keep On Your Radar

1. Greenlane Holdings, Inc. (NASDAQ:GNLN)
2. Jushi Holdings Inc. (OTC:JUSH)

Greenlane Holdings, Inc.

Greenlane Holdings, Inc. engages in the development and distribution of cannabis accessories, vape devices, and lifestyle products in the United States, Canada, Europe, and Latin America. It has been some time since the company has reported any new updates.

But on March 25th, the company announced it would join the Mainstem B2B procurement marketplace platform. MainStem offers an end-to-end, enterprise-level supply chain solution designed to streamline procurement for the legal cannabis industry.

[Read More] These Cannabis Stocks Could Pay Off Big In The Future

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for the medical and adult-use markets in the United States. On May 8th, the company reported its first quarter of 2025.

[Read More] 3 Marijuana Stocks For Cannabis Real Estate Investors

First Quarter 2025 Financial Highlights

• Total revenue of $63.8 million
• Gross profit and gross profit margin of $25.8 million and 40.4%, respectively
• Net loss of $17.0 million
• Adjusted EBITDA1 and Adjusted EBITDA margin1 of $9.8 million and 15.4%, respectively
• Cash, cash equivalents, and restricted cash of $27.9 million as of quarter end
• Net cash flows provided by operations of $7.5 million

The post 2 Marijuana Stocks That Could Make You Money In 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The way the cannabis industry is booming, you would think this success would help marijuana stocks. However, this has not been the case, but that has not stopped the industry from thriving. Right now is a unique time for legal cannabis and the companies in the industry. For the companies that are publicly traded, they are truly feeling the impact of what’s occurring.

Now, this isn’t to say things can not change for the better. But at this time, that is not the case. For the more optimistic investors, they see cannabis as buy now, sell later. Especially with all the success and revenue being made. It is one of those things where patience is key, and you need to be willing to take the risk. Almost all of America has some form of legal cannabis market. Each market, for better or worse, is making cash flow, and if money is being made, then there is opportunity on the horizon.

Even with a massive downtrend, once things change from a federal and regulatory standpoint point marijuana stocks could rapidly shoot up. Currently, this is a time to observe and strategize as the industry further expands. The 2 marijuana stocks to watch that are mentioned below are potential companies that may hold the potential to yield profits in 2025.

Top Marijuana Stocks In Down Trend

1. Planet 13 Holdings Inc. (OTC:PLNH)
2. Verano Holdings Corp. (OTC:VRNOF)

Planet 13 Holdings Inc.

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States. During the months of April and May, the company has made 2 new announcements.

On April 29th, the company announced the opening of a new Florida Dispensary. The grand opening of Planet 13 Edgewater will be on May 31, 2025, the Company’s 33rd dispensary in Florida and 37th nationwide. However, on May 7th announced today that it plans to release its financial results for the first quarter ended March 31st, 2025, on May 14th, 2025, after the market.

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States.  The company like others in the space have recently reported Q1 2025 earnings.

First Quarter 2025 Financial Highlights

• Revenues, net of discounts, of $210 million, a decrease of 5% year-over-year, and a decrease of 4% versus the prior quarter.
• Gross profit of $100 million or 47% of revenue.
• SG&A expenses of $85 million or 40% of revenue.
• Net Loss of $(12) million or (5)% of revenue.
• Adjusted EBITDA1 of $54 million or 26% of revenue.

Words From The CEO

“I am very pleased with the progress we made during the first quarter executing our strategic priorities leveraging innovation, automation and differentiation, while driving efficiencies across the business,” said George Archos, Verano founder, chairman and Chief Executive Officer.”

The post These 2 Marijuana Stocks Are Making Money Outside Of The Stock Market appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Is it safe to invest in marijuana stocks with the entire sector trading at all-time lows? If the legal market is profitable and companies are performing well, why are the top marijuana stocks not trading? These are just some of the questions that plague investors and shareholders. The answer is not so simple, which can make things a bit more complex to understand. Although legal cannabis as a business is thriving and growing in all areas, this has not translated to the public sector so well.

Some feel that it’s like walking on a razor blade without better laws in place on the federal level. There is still much fear of what could happen without federal reform or even SAFE Banking in an industry generating billions of dollars. Legal cannabis has come such a long way that it is just a matter of when. But without it in place, it has hurt the confidence of many investors.

Now, what other areas of cannabis investing could be good are companies that do not solely deal directly with the plant. The ancillary side of cannabis could be a potential haven for better profits at this time. With all things, nothing is a guarantee, and with proper planning, you could see a return. The marijuana stocks to watch below are companies that are in cannabis but do not rely only on the industry to be successful.

Top Ancillary Marijuana Stocks For You

1. Innovative Industrial Properties, Inc. (NYSE:IIPR)
2. NewLake Capital Partners, Inc. (OTC:NLCP)
3. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership, and management of specialized properties.

Particularly properties leased to experienced, state-licensed operators for their regulated cannabis facilities. Recently, the company reported its Q1 2025 earnings.

Highlights Key Mentions

• Innovative Industrial Properties Inc reported total revenues of $71.7 million and adjusted funds from operations (AFFO) of $55.3 million for the first quarter of 2025.
• The company ended the period with over $220 million in total liquidity, showcasing a strong financial position.
• IIPR successfully acquired a $7.8 million industrial facility in Maryland and executed two new leases totaling 211,000 square feet.

NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally managed real estate investment trust that provides real estate capital to state-licensed cannabis operators.

This is done through a sale-leaseback transaction, third-party purchases, and funding for build-to-suit projects. On May 7th, the company reported its 2025 first quarter results.

First Quarter 2025 Financial and Operational Highlights

• Revenue totaled $13.2 million.
• Net income attributable to common stockholders totaled $6.3 million.
• Funds From Operations (“FFO”)(2) totaled $10.3 million.
• Adjusted Funds From Operations (“AFFO”)(2) totaled $10.7 million.
• Declared a first quarter dividend of $0.43 per common share, equivalent to an annualized dividend of $1.72 per common share.

[Read More] Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial mortgage real estate investment trust in the United States.

The company engages in originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. In more recent news, the company has reported its Q1 2025 financial results.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

First Quarter 2025 Financial Highlights

• Net interest income of approximately $13.0 million as of March 31, 2025.
• Total expenses of approximately $4.1 million before provision for current expected credit losses, representing a sequential decrease of approximately 28.3%.
• Net Income of approximately $10.0 million, or $0.47 per weighted average diluted common share, representing a sequential increase of 20.5% on a per share basis.

The post 3 Marijuana Stocks For Cannabis Real Estate Investors appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

In recent weeks, cannabis penny stocks have attracted cautious investor interest. First, the U.S. legal cannabis market reached $33.6 billion in 2023. Moreover, it is projected to grow at a 12.1 percent CAGR through 2030. Meanwhile, employment in the sector surpassed 440,000 full‑time jobs nationwide. At the same time, federal reform remains stalled despite rescheduling momentum. For instance, the DEA’s proposed move to Schedule III could reshape banking access. In addition, states push new bills. Notably, Pennsylvania lawmakers debate privatized dispensaries to unlock $250 million in annual tax revenue. Likewise, the Supreme Court’s recent RICO decision heightens compliance risks across the industry. Therefore, cannabis penny stocks offer both opportunity and volatility this week. Consequently, traders should combine fundamental awareness with market context before entry.

Furthermore, technical analysis can guide precise entry and exit points. For example, watch for clear breakouts above key moving averages. Likewise, identify volume spikes on relative strength index (RSI) signals near oversold levels. At the same time, set stop-loss orders below recent swing lows to limit downside. Moreover, position sizing based on a fixed percentage of portfolio capital prevents outsized losses. In addition, traders should monitor broader market correlations to cannabis ETFs and equities.

Meanwhile, avoid headline risks, such as state-level vetoes or federal delays. Finally, combine chart patterns—like double bottoms or bullish engulfing candles—with strict risk rules. By doing so, investors can pursue gains in penny stocks while containing exposure in this still-evolving industry.

[Read More] These Cannabis Stocks Could Pay Off Big In The Future

Top U.S. Marijuana Stocks to Watch in May 2025

The Cannabist Company Holdings Inc. (OTC: CBSTF)

Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Verano Holdings Corp. (OTC: VRNOF)

The Cannabist Company Holdings Inc. (OTC: CBSTF)

The Cannabist Company, previously known as Columbia Care, is one of the largest vertically integrated cannabis firms in the U.S. Its largest presence is in Florida, New York, and Virginia. As of May 2025, it operates 67 dispensaries across 14 U.S. states. In addition, the company runs 17 cultivation and processing facilities. It offers branded products through in-house lines like Triple Seven and Seed & Strain. Its retail stores are focused on a consistent customer experience. Furthermore, the company has embraced digital marketing and loyalty programs. This helps build stronger customer retention. Recently, it has closed underperforming locations in saturated markets. At the same time, it is focusing on growing markets with long-term upside. These strategic shifts aim to boost margins and reduce overhead. The company focuses on improving operations, scaling sustainably, and navigating changing regulations.

In Q1 2025, the Cannabist Company reported $87 million in revenue. This was slightly lower than the same quarter last year. However, the company improved gross margins by reducing operational costs and optimizing cultivation. Management also reduced SG&A expenses. This improved operational efficiency across its footprint. The net loss narrowed meaningfully compared to the prior year. Additionally, the company successfully restructured a portion of its debt. Lower interest costs are expected in future quarters. Adjusted EBITDA showed improvement, even with modest revenue softness. Cash from operations turned positive for the first time in several quarters. This is a key sign of improving financial health. Liquidity also improved due to better inventory management. Looking forward, management expects stabilization through the second half of 2025. As a result, the company is well-positioned to benefit from future industry growth.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

 Cansortium Inc. (OTC: CNTMF) – Doing Business as Fluent

Cansortium Inc., now operating as Fluent, is a medical marijuana operator with a strong Florida focus. The company currently operates over 30 dispensaries in Florida alone. Outside Florida, it operates in Texas, Pennsylvania, and New York. Fluent also recently expanded into Ohio, adding several co-located dispensaries. Its brand is built on wellness and customer education. Many locations offer pharmacist-led consultations. This builds trust and improves patient experience. Fluent offers a wide range of products. These include flower, concentrates, tinctures, and pre-rolls. The company continues to grow by adding high-performing retail sites in emerging markets. It also seeks joint ventures and local partnerships to reduce entry barriers. With a vertically integrated model, it controls the supply chain from seed to sale. This gives it pricing flexibility and operational consistency. Fluent remains committed to steady, profitable growth in medically focused markets.

Fluent posted $63.8 million in revenue for Q1 2025. This marked a slight decline year-over-year. Retail sales fell slightly due to price compression, though overall unit volume increased. Wholesale sales declined as bulk deals slowed in some markets. However, states like Virginia and Ohio posted strong retail gains. Gross profit came in at $25.8 million, with margins compressed slightly from prior quarters. Operating expenses totaled $27.6 million, which was a modest improvement. Fluent reported a net loss of $17 million in Q1. Interest expenses and depreciation continued to weigh on results. However, adjusted EBITDA was $9.8 million, down from $13.3 million in the previous year. Despite short-term softness, the company’s financials are stabilizing. Investments in Ohio and Virginia are expected to deliver growth in future quarters. Fluent is also improving cash flow and reducing non-essential costs. These steps should help strengthen its financial foundation.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Verano Holdings Corp. (OTC: VRNOF)

Verano Holdings is a major multi-state cannabis operator based in Chicago. It operates in 16 U.S. states and serves both medical and adult-use markets. As of May 2025, Verano runs more than 100 dispensaries. Its largest retail presence is in Florida, Illinois, and Nevada. Verano is known for its premium retail brands like Verano and MÜV. These stores are highly curated and focus on customer experience. The company also owns cultivation and processing facilities in key states. It uses vertical integration to manage costs and ensure consistent product quality. Verano expands through both organic growth and acquisitions. Recent moves have focused on acquiring licenses in underserved regions. It also partners with local operators to reduce risk. Leadership has emphasized careful scaling and integration. As a result, the brand reputation remains strong across regions. The company’s structure supports long-term scalability and margin growth.

In Q1 2025, Verano reported $210 million in revenue. This marked a strong increase compared to the prior year. The company recorded a net loss of $12 million for the quarter. However, adjusted EBITDA improved as gross margins expanded. Verano also generated $2 million in operating cash flow. Although capital expenditures remained high, the company managed costs effectively. Its balance sheet remains healthy, with reasonable levels of debt and cash on hand. Management continues to reinvest in new store openings and cultivation upgrades. These investments are expected to fuel future revenue growth. The company aims to reach profitability by late 2026. Analysts have highlighted Verano’s disciplined approach as a key advantage. By focusing on core markets and sustainable operations, it has built a resilient business model. Financial performance is expected to improve further as markets mature and efficiencies scale.

Leading U.S. Marijuana Stocks for May 2025

May 2025 presents a unique moment for cannabis investors. The U.S. industry is expanding amid evolving legalization trends. Companies like The Cannabist Company, Fluent, and Verano offer diverse exposure. Each firm operates in multiple states and controls a significant market share. Despite recent margin pressures, they are improving operational efficiency and cash flow. These names are well-positioned for long-term success in the cannabis sector. For investors, they represent top U.S. marijuana stocks to watch in 2025.

The post Cultivate Your Portfolio: U.S. Cannabis Stocks for May 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF),  (“Charlotte’s Web” or the “Company”), a botanical wellness innovation company, today announced results for the quarter ended March 31, 2025, reporting its first year-over-year revenue increase in more than three years, building on the sequential quarterly growth trend achieved in 2024.

“Following three sequential quarters of improvement in 2024, Q1 delivered our first year-over-year revenue growth since 2021 – validating the transformation we initiated 18 months ago,” said Bill Morachnick, Chief Executive Officer. “Our upgraded e-commerce platform is converting more visitors, and new digital storefronts on Amazon, TikTok Shop, and Faire are widening our reach. An upcoming nationwide rollout with Whole Foods Market will strengthen our retail footprint. Operationally, we commenced initial in–house gummy production and, as part of our disciplined cost agenda, we mutually concluded our promotional rights agreement with MLB and associated costs. Coupled with robust innovation – including cannabinoid isolates and our new functional mushroom gummy line – we believe these initiatives position the Company to deliver top and bottom-line growth for 2025 and beyond.”

Erika Lind, Chief Financial Officer, added, “Our reengineered cost structure is now flowing through the P&L. Building on the positive traction from the prior quarters, we are structuring for further improvements in cost efficiency and cash flow. As a part of this effort, we have concluded some high-cost promotional sports agreements, thereby eliminating sizeable future cash outlays of more than $18 million over the next three years. This supports near-term cash flow and preserves long-term cash for further investment in innovation. Combined with our transitioning to in-house manufacturing and disciplined SG&A control, we anticipate further improvements to cash flow in 2025.”

First Quarter Business Review

Expansion of Mushroom Wellness Gummy Innovations
Following the successful Q4 2024 launch of its functional mushroom gummies targeting focus, stress, and energy, Charlotte’s Web will continue expanding its botanical wellness portfolio in 2025. The Company’s strategic diversification beyond CBD is gaining market traction with mushroom wellness products now available through multiple distribution channels, including Walmart.com, Amazon.com, and the Company’s direct-to-consumer platform.

E-Commerce Growth and Omnichannel Expansion
Building on the sequential gains recorded in 2024, Charlotte’s Web’s digital channels delivered year-over-year growth in Q1 2025. Order volume growth, stabilized average order values, new subscriber increases, and lower churn rates drove meaningful digital revenue growth and underscored brand loyalty. This performance reflects the past year’s technology and go-to-market enhancements: a unified brand architecture, an expanded product portfolio, data-driven segmentation, an upgraded e-commerce stack, and improved engagement tools such as SMS outreach and an influencer network that now reaches more than one million consumers.

The Company has widened its omnichannel footprint. Walmart.com added Charlotte’s Web’s new mushroom wellness gummies during the quarter, while strategic launches on Amazon, TikTok Shop, and Faire have dramatically broadened online reach. With additional categories and channels slated for launch in the coming quarters, the Company is well-positioned to meet consumers wherever they shop, diversifying revenue streams, and capturing incremental market share through improved digital discoverability.

Whole Foods Market Retail Distribution Launch
In a significant advancement of its retail expansion, the Company achieved a major milestone finalizing an agreement with Whole Foods Market to roll out products to more than 400 store locations nationwide. As part of this partnership, three isolate topical products will be available on shelves starting June 2025. This launch marks a significant step forward in making botanical wellness solutions more accessible to health-conscious consumers seeking trusted, plant-based alternatives.

Operational Efficiencies and Cost Management
Expense reductions initiated in 2024 continued to benefit operating performance, with year-over-year operating costs down 24.2%. Strengthening operations, Charlotte’s Web began preliminary in-house commercial production of gummies in Q2 2025, supporting gross margins and speed-to-market for new products. This production shift will enable the rapid development of new gummy blends.

“With successful expansion into new product categories, improving cash flow metrics, and enhanced operational efficiencies, Charlotte’s Web has a good start to 2025,” added Mr. Morachnick. “Our disciplined execution of strategic initiatives – from platform expansion to manufacturing optimization – positions us to build on this throughout 2025 and beyond, delivering value for shareholders and continued innovation for consumers.”

DeFloria Milestone
In the first quarter, DeFloria, Inc. – a joint entity established between Charlotte’s Web and Ajna BioSciences, with British American Tobacco as lead investor – received U.S. Food and Drug Administration (FDA) clearance to initiate Phase 2 clinical trials for its botanical pharmaceutical candidate, AJA001 Oral Solution, intended to treat irritability associated with autism spectrum disorder (“ASD”). AJA001 is formulated using Charlotte’s Web proprietary full-spectrum CBD extract derived from its patented cultivars. The FDA’s acceptance of DeFloria’s IND for AJA001 marks a significant milestone. In addition, Charlotte’s Web holds manufacturing rights for commercial supply when the drug is ultimately approved by the FDA, representing a potential opportunity that could be transformative for Charlotte’s Web over time.

On June 9, 2025, Charlotte’s Web and Ajna BioSciences will host an executive panel session at the Benzinga Cannabis Capital Conference in Chicago. As part of the panel discussion, Charlotte’s Web will showcase its partnership with DeFloria and AJA001’s clinical progress and therapeutic potential. For attendance information, contact IR@defloira.bio.

First Quarter 2025 Financial Review
The following table sets forth selected financial information for the periods indicated:

Three months ended

March 31,

U.S. $ millions, except per share data

2025

2024

Revenue

$

12.3

$

12.1

Cost of goods sold

$

6.1

$

5.2

Gross profit

6.2

6.9

Selling, general and administrative expenses

11.6

15.3

Operating loss

(5.4)

(8.4)

Change in fair value of financial instruments and other

(0.1)

(1.9)

Other income (expense) , net

(0.7)

0.6

Net loss

$

(6.2)

$

(9.7)

EPS basic and diluted

$

(0.04)

$

(0.06)

Adjusted EBITDA(1)

$

(2.8)

$

(3.9)

Assets:

Cash and cash equivalents

$

19.4

Total assets

$

108.0

Liabilities:

Long-term liabilities

$

68.5

Total liabilities

$

87.0

Quarterly revenue trend:

Q1

Q2

Q3

Q4

Q1

U.S. $ millions

2024

2024

2024

2024

2025

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

$ 12.3

Consolidated net revenue for the first quarter ended March 31, 2025, was $12.3 million, a year-over-year increase of 1.1% compared to $12.1 million in the first quarter of 2024. Propelled by the continued performance of the Company’s upgraded e-commerce platform, this represents the first period of year-over-year growth reported since Q2 2021 and builds upon a consecutive quarterly growth trend established in 2024. Introduced in mid-2024, the new platform has delivered measurable improvements in marketing effectiveness, customer engagement, and sales volumes. The Company also continues to generally outperform its peers in retail category benchmarks, reflecting the strength of its recent product innovations and the effectiveness of its strategic retail partnerships.

Gross profit in Q1 2025 was $6.2 million, or 50.8% of revenue, compared to gross profit of $6.9 million, or 57.0% of revenue, in Q1 2024. The prior year included temporary items favorable to gross margin. The Company models forward gross margin percentages to continue in the low 50s, supported partly by the transition to in-house production of gummies, followed by topical products over time.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $11.6 million, a 24.2% improvement from $15.3 million in Q1 2024. Stringent expense controls were implemented over the past year and remain a central focus in 2025.

Net loss for the first quarter of 2025 was $6.2 million, or ($0.04) per share basic and diluted, compared to a net loss of $9.7 million, or ($0.06) per share basic and diluted, for the first quarter of 2024.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported negative Adjusted EBITDA1 for the first quarter of 2025 of $2.8 million, a $1.1 million improvement compared to negative Adjusted EBITDA of $3.9 million in the first quarter of 2024.

Balance Sheet and Cash Flow
Net cash used for operations in the first quarter of 2025 was $2.8 million. The Company’s cash and working capital as of March 31, 2025, were $19.4 million and $25.5 million, respectively, compared to $22.6 million and $31.1 million as of December 31, 2024, respectively.

“With cash reserves exceeding $19 million and our anticipated cash flow improvements for this year, we are confident our balance sheet is sufficient to support growth for 2025 and beyond,” said Mrs. Lind.

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s consolidated financial statements and accompanying notes for the three month periods ended March 31, 2025, and 2024, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-Q filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is a botanical wellness innovation company and market leader in hemp extract wellness that includes Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and are available online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information

Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance, and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions, expected future development, and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume and gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the Company’s ability to increase online traffic and demographic exposure through new products and marketing and omni-channel expansion; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory; launch of products in Whole Foods; continued product placement on various product channels; anticipated development of new products; the outcomes from DeFloria’s clinical trials, including commercial opportunities for Charlotte’s Web.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty, as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars, except share and per share amounts)

March 31,

December 31,

2025 (unaudited)

2024

ASSETS

Current assets:

Cash and cash equivalents

$ 19,357

$ 22,618

Accounts receivable, net

1,531

1,263

Inventories, net

18,916

18,907

Prepaid expenses and other current assets

4,201

4,194

Total current assets

44,005

46,982

Property and equipment, net

25,758

26,337

License and media rights

12,717

13,691

Operating lease right-of-use assets, net

12,404

12,876

Investment in unconsolidated entity

10,700

10,800

SBH purchase option and other derivative assets

970

1,075

Intangible assets, net

1,003

1,049

Other long-term assets

466

632

Total assets

$ 108,023

$ 113,442

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,943

$ 3,426

Accrued and other current liabilities

4,764

5,246

Lease obligations – current

1,844

2,055

License and media rights payable – current

7,937

5,209

Total current liabilities

18,488

15,936

Convertible debenture

44,753

43,631

Lease obligations

13,257

13,652

License and media rights payable

9,227

11,809

Derivative and other long-term liabilities

1,236

1,327

Total liabilities

86,961

86,355

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and
158,009,541 shares issued and outstanding as of March 31, 2025 and December
31, 2024

1

1

Additional paid-in capital

328,842

328,655

Accumulated deficit

(307,781)

(301,569)

Total shareholders’ equity

21,062

27,087

Total liabilities and shareholders’ equity

$ 108,023

$ 113,442

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except share and per share amounts)

Three Months Ended March 31,
(unaudited)

2025

2024

Revenue

$ 12,262

$ 12,124

Cost of goods sold

6,032

5,213

Gross profit

6,230

6,911

Selling, general, and administrative expenses

11,578

15,280

Operating loss

(5,348)

(8,369)

Change in fair value of financial instruments

(126)

(1,860)

Other income (expense), net

(738)

611

Loss before provision for income taxes

$ (6,212)

$ (9,618)

Income tax expense

—

(16)

Net loss

$ (6,212)

$ (9,634)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.04)

$ (0.06)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Shares

Amount

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

Common shares issued upon vesting of restricted share units,
net of withholding

—

—

—

—

—

Share-based compensation

—

—

187

—

187

Net loss

—

(6,212)

(6,212)

Balance—March 31, 2025

158,009,541

$ 1

$ 328,842

$ (307,781)

$ 21,062

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units,
net of withholding

2,895,489

—

(98)

—

(98)

Share-based compensation

—

842

—

842

Net loss

—

(9,634)

(9,634)

Balance—March 31, 2024

157,227,855

$ 1

$ 328,024

$ (281,357)

$ 46,668

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Three Months Ended March 31,
(unaudited)

2025

2024

Cash flows from operating activities:

Net loss

$ (6,212)

$ (9,634)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

2,449

2,493

Change in fair value of financial instruments

126

1,860

Convertible debenture and other accrued interest

868

1,015

Changes in right-of-use assets

473

443

Share-based compensation

187

842

Other

126

(956)

Changes in operating assets and liabilities:

Accounts receivable, net

(394)

98

Inventories, net

19

(1,026)

Prepaid expenses and other current assets

28

150

License and media rights

—

(2,500)

Operating lease obligations

(605)

(551)

Accounts payable, accrued and other liabilities

71

663

Other operating assets and liabilities, net

96

(76)

Net cash used in operating activities

(2,768)

(7,179)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(521)

(2,060)

Proceeds from sale of assets

28

27

Net cash used in investing activities

(493)

(2,033)

Cash flows from financing activities:

Other financing activities

—

(98)

Net cash used in financing activities

—

(98)

Net decrease in cash and cash equivalents

(3,261)

(9,310)

Cash and cash equivalents —beginning of period

22,618

47,820

Cash and cash equivalents —end of period

$ 19,357

$ 38,510

Non-cash activities:

Non-cash purchase of property and equipment and intangible assets

$ (83)

$ (374)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financial measures do not have a standardized meaning prescribed under U.S. GAAP and, therefore, may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

Adjusted EBITDA for the three months ended March 31, 2025, and 2024 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended
March 31,
(unaudited)

U.S. $ Thousands

2025

2024

Net loss

$

(6,212)

$

(9,618)

Depreciation of property and equipment and amortization of intangibles

2,449

2,493

Interest expense

685

487

Income tax expense

16

EBITDA

(3,078)

(6,622)

Share-based compensation

187

842

Mark-to-market financial instruments

126

1,860

Adjusted EBITDA

$

(2,765)

$

(3,920)

SOURCE Charlotte’s Web Holdings, Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2025/14/c3289.html

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports Year-Over-Year Growth For Q1 2025 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

The cannabis industry has faced significant challenges in recent years, leading to a downturn in marijuana stock prices. Despite the current market conditions, there may be a strategic opportunity for investors. With how low the sector has fallen, this risk vs reward opportunity could be profitable. The cannabis sector needs a big momentum change and an impactful catalyst to do so.

This is where many feel the passing of federal reform will be the dominant shift for most marijuana stocks. Market corrections are often where real value is found. Cannabis stocks are currently trading at historically low price-to-sales and price-to-book ratios. What this means is investors can find top marijuana stocks to buy at steal valuations. Now, most of the time it is a waiting game as to when a volatile pop will occur, so long-term planning is what’s occurring.

In short, while the cannabis sector has faced headwinds, current lows may not reflect the long-term potential of the industry. For investors willing to be patient, the current downtrend could be a rare chance to buy low before the next wave of growth begins. Just make sure you do your research and develop a trading strategy that works for you. Below are several marijuana stocks to watch today.

Marijuana Stocks For Your 2025 Portfolio

1. FLUENT Corp. (OTC:CNTMF)
2. Glass House Brands Inc.(OTC:GLASF)
3. Ascend Wellness Holdings, Inc. (OTC:AAWH)

FLUENT Corp.

FLUENT Corp., through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

In recent news, the company released New York Minute, a bold new addition to its MOODS vaporizer portfolio. The new offering will be available in two convenient All-in-One device formats: a 1g Mini and a 0.5g Dash, catering to consumers who seek portability, performance,e and taste.

Words From The CEO

“New York sets the tone for culture, innovation, and lifestyle—and we wanted to create a vape product that connects with that essence,” said Robert Beasley, CEO of FLUENT.”

Glass House Brands Inc.

Glass House Brands Inc. operates as an integrated cannabis company in the United States. The company operates in three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

The company has recently announced in partnership with LEEF Brands Inc. This Management Services Agreement Glass House will manage operations of LEEF’s Palm Desert, California, dispensary, “The Leaf El Paseo,” on behalf of LEEF. Glass House will assume daily management responsibilities of The Leaf El Paseo.

[Read More] 3 Marijuana Stocks For Long-Term Investing 2025

Ascend Wellness Holdings, Inc.

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.

In recent updates, the company has reported its Q1 2025 earnings.

[Read More] Best Canadian Marijuana Stocks for U.S. Market Exposure

Financial Highlights
Revenue:

• Total net revenue declined 5.9% quarter-over-quarter to $128.0 million.
• Retail revenue decreased 6.6% quarter-over-quarter to $84.4 million.
• Wholesale revenue decreased 4.4% quarter-over-quarter to $43.6 million.
  Net Loss:
• Net loss of $19.3 million in Q1 2025 compared to net loss of $16.8 million in Q4 2024.

The post These Cannabis Stocks Could Pay Off Big In The Future appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis-infused gummies, Very Berry Rocket and Cherry Blasted Lime, all crafted to provide consumers with nostalgic sour flavours.

XMG Atomic Sours beverages, including Cherry Blasted Lime and Foggy Peaches, offer nostalgic super sour flavors. Each beverage contains 10mg THC, 10mg CBG, and Guarana extract, providing 30mg of naturally occurring caffeine. These beverages are fast-acting due to nano-emulsified THCA diamonds.

The XMG Atomic Sours Gummies, available in Very Berry Rocket and Cherry Blasted Lime flavors, mark the brand’s entry into the edibles market. This expansion diversifies the brands’ product portfolio and caters to emerging consumer preferences. Each gummy is shaped like a nostalgic “key” and comprises 10mg of nano-emulsified THC and 10mg of CBG. These gummies deliver an intensely sour experience and are crafted using plant-based pectin.

XMG Atomic Sours are now available nationwide at select retailers. To find XMG’s most recent thirst quenchers and key-shaped gummies and to keep up with the latest news from XMG, follow @findyourXMG on Instagram.

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) is a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on Tilray Brands, visit www.Tilray.com and follow @Tilray.

The content above is on behalf of Aphria Inc., High Park Holdings Ltd., as licensed producers.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

For more information

Media Contact: news@tilray.com

Investor Contact: investors@tilray.com

The post Tilray Brands, Inc. (TLRY) Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..